Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Mounjaro ® ▼ (tirzepatide)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk
How to dispose of Mounjaro® (tirzepatide) KwikPens® and needles
After removing the needle, discard the empty pen in a sharps container or household waste. Dispose of the needles in a sharps container.
How many doses are in the KwikPen?
Each KwikPen contains 4 doses. After 4 doses, dispose of the pen. Do not use beyond 30 days after first use.1
Can the KwikPens be refilled or recycled?
Empty KwikPens must not be re-filled and must be properly discarded.2
The KwikPens cannot be recycled.2
How should patients dispose of the needles?
After completing the injection, patients should:1
- carefully replace the outer needle shield
- unscrew the capped needle, and
- put used pen needles in a sharps disposal container immediately after use.
Patients should NOT discard loose pen needles in household waste.1
Advise patients to NOT recycle their used sharps disposal container.1
How should patients dispose of the empty KwikPen?
After removing the needle, patients should discard the used KwikPen in household waste or a sharps disposal container.1
How to dispose of unused medicinal product
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.3
References
1Mounjaro [instructions for use]. Eli Lilly Nederland B.V., The Netherlands. (GB)
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
3Mounjaro [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Date of Last Review: 05 February 2024